Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 215

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Skeletal muscle density predicts prognosis in patients with metastatic renal cell carcinoma treated with targeted therapies

Antoun, Sami, Lanoy, Emilie, Iacovelli, Roberto, Albiges‐Sauvin, Laurence, Loriot, Yohann, Merad‐Taoufik, Mansouriah, Fizazi, Karim, di Palma, Mario, Baracos, Vickie E., Escudier, Bernard · 2013 · Cancer

Abstract

BACKGROUND: Studies have shown that skeletal muscle and adipose tissue are linked to overall survival (OS) and progression‐free survival (PFS). Because targeted therapies have improved the outcome in patients with metastatic renal cell carcinoma (mRCC), new prognostic parameters are required. The objective of the current study was to analyze whether body composition parameters play a prognostic role in patients with mRCC. METHODS: Adipose tissue, skeletal muscle, and skeletal muscle density (SMD) were assessed with computed tomography imaging by measuring cross‐sectional areas of the tissues and mean muscle Hounsfield units (HU). A high level of mean HU indicates a high SMD and high quality of muscle. OS and PFS were estimated using the Kaplan‐Meier method and compared with the log‐rank test. The multivariable Cox proportional hazards model was adjusted for Heng risk score and treatment. RESULTS: In the 149 patients studied, the median OS was 21.4 months and was strongly associated with SMD; the median OS in patients with low SMD was approximately one‐half that of patients with high SMD (14 months vs 29 months; P = .001). After adjustment for Heng risk score and treatment, high SMD was associated with longer OS (hazards ratio, 1.85; P = .004) and longer PFS (hazards ratio, 1.81; P = .002). Adding SMD will separate the intermediate‐risk and favorable‐risk groups into 3 groups, with different median OS periods ranging from 8 months (95% confidence interval [95% CI], 6 months‐12 months) for an intermediate‐risk Heng score/low SMD to 22 months (95% CI, 14 months‐27 months) for an intermediate‐risk Heng score/high SMD and a favorable‐risk Heng score/low SMD to 35 months (95% CI, 24 months‐43 months) for a favorable‐risk Heng score/high SMD. CONCLUSIONS: High muscle density appears to be independently associated with improved outcome and could be integrated into the prognostic scores thereby enhancing the management of patients with mRCC. Cancer 2013;119:3377–84. © 2013 American Cancer Society.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/cncr.28218

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 215

Metadata

Authors
Antoun, S., Lanoy, E., Iacovelli, R., Albiges‐Sauvin, L., Loriot, Y., Merad‐Taoufik, M., Fizazi, K., di Palma, M., Baracos, V. E., & Escudier, B.
Venue
Cancer
Publisher
Wiley
Published
2013-06-25
Volume
119
Issue
18
Pages
3377-3384
ISSN
  • 0008-543X (ISSN-L)
  • 1097-0142
OpenAlex
W1577090346
Cited by
215
References
4
FWCI
11.94
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Skeletal muscle density predicts prognosis in patients with metastatic renal cell carcinoma treated with targeted therapies. https://app.cochat.ai/papers/10.1002/cncr.28218
The paper
Antoun, S., Lanoy, E., Iacovelli, R., Albiges‐Sauvin, L., Loriot, Y., Merad‐Taoufik, M., Fizazi, K., di Palma, M., Baracos, V. E., & Escudier, B. (2013). Skeletal muscle density predicts prognosis in patients with metastatic renal cell carcinoma treated with targeted therapies. Cancer. https://doi.org/10.1002/cncr.28218

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.